Improving cardiovascular risk stratification in essential hypertensive patients by indexing left ventricular mass to height2.7

Journal of Hypertension

Volumn 27, Issue 12, 2009, Pages 2465-2471

  Cuspidi, Cesare ^a,b   Giudici, Valentina ^b   Negri, Francesca ^a,b   Meani, Stefano ^c   Sala, Carla ^d   Zanchetti, Alberto ^b,d   Mancia, Giuseppe ^a,b,d  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c RHO HOSPITAL   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Hypertension; Left ventricular hypertrophy; Left ventricular mass indexation

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BODY SURFACE; CARDIOVASCULAR RISK; CAROTID ARTERY; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE SIZE; HEIGHT; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; OBESITY; ORGAN INJURY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RETINOPATHY; RISK ASSESSMENT; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

EID: 73649128348     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32833105a6     Document Type: Article

References (22)

1. Haider AW, Larson MG, Benjamin EJ, Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol 1998; 32:1454-1459. (Pubitemid 28522409)
2. Milani RV, Lavie CJ, Mehera MR, Ventura HO, Kartz JD, Messerll F. Left ventricular geometry and survival In patients with normal left ventricular ejection fraction. Am J Cardiol 2006; 97:959-963.
3. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al., the task force for the management of arterial hypertension of the European Society of Hypertension, the task force for the management of arterial hypertension of the European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:11051187.
4. Lang RM, Bierig M, Devereux RB, Flaohskampf FA, Foster E, Pellikka PA, et al., Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Chamber Quantification Writing Group, developed In conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:1440-1463.
5. Hammond IW, Devereux RB, Alderman MH, Laragh JH. Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive adults. J Am Coll Cardiol 1998; 12:996-1004.
6. Pelliccia A, Culasso F, Di Paolo FM, Maron BJ. Physiologic left ventricular cavity dilatation In elite athletes. Ann Intern Med 1999; 130:23-31.
7. Bella JN. Indexation of left ventricular mass to identify blood pressurerelated left ventricular hypertrophy. Am J Hypertens 2005; 18:12631265.
8. Dewey FE, Rosenthal D, Murphy DJ, Froelicher VF, Ashley EA. Does size matter? Clinical applications of scaling cardiac size and function for body size. Circulation 2008; 117:2279-2287.
9. de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh J. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their predictive capacity to predict cardiovascular risk. J Am Coll Cardiol 1995; 25:1056-1062.
10. Cuspidi C, Meani S, Negri F, Giudici V, Valerio C, Sala C, et al. Indexation of left ventricular mass to body surface area and height to allometric power of 2.7: is the difference limited to obese hypertensives? J Hum Hypertens 2009; 23:728-734.
11. de Simone G, Kizer JR, Chinali M, Roman MJ, Bella JN, Best LG, et al., For the Strong Heart Study Investigators. Normalization for body size and population attributable risk of left ventricular hypertrophy. Am J Hypertens 2005; 18:191-196. (Pubitemid 40332548)
12. Ferrara LA, Vaccaro O, Cardoni O, Laurenzi M, Mancini M, Zanchetti A. Indexation criteria of ventricular mass and predictive role of blood pressure and body composition. Am J Hypertens 2005; 18:1282-1287. (Pubitemid 41400195)
13. Coca A, Gabriel R, de la Figuera M, Lopez-Sendon JL, Fernandez R, Sagastagoitia JD, et al., On behalf the VITAE Investigators. The impact of different echocardiographic diagnostic criteria on the prevalence of left ventricular hypertrophy in essential hypertension. J Hypertens 1999; 17:1471-1480. (Pubitemid 29509494)
14. Wacthell K, Bella JN, Liebson PR, Gerdts E, Dahlof B, Aalto T, et al. Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population. The LIFE study. Hypertension 2000; 35:6-12. (Pubitemid 30054229)
15. Cuspidi C, Meani S, Valerio C, Sala C, Fusi V, Zanchetti A, Mancia G. Age and target organ damage in essential hypertension: role of the metabolic syndrome. Am J Hypertens 2007; 20:296-303. (Pubitemid 46283362)
16. Devereux RB, Reickek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977;55:613-618. (Pubitemid 8066109)
17. Pignoli P, Tremoli E, Poli A, Paoletti R. Intimal plus media thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986;74:1399-1408. (Pubitemid 17189260)
18. Cuspidi C, Lonati L, Macca G, Sampieri L, Fusi V, Michev I, et al. Prevalence of left ventricular hypertrophy and carotid thickening in a large selected population: impact of different echocardiographic and ultrasonographic diagnostic criteria. Blood Press 2001 ; 10:142-149. (Pubitemid 32982494)
19. Cuspidi C, Meani S, Salerno M, Fusi V, Severgnini B, Valerio C, et al. Retinal microvascular changes and target organ damage in untreated essential hypertensives. J Hypertens 2004; 22:2095-2102. (Pubitemid 39463801)
20. Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palù C, et al. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine study on Atherosclerosis. J Hypertens 1998; 16:949-961. (Pubitemid 28367949)
21. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeuw D, van Veldhuisen DJ, et al. Urinary albumin excretion predicts cardiovascular and non cardiovascular mortality in general population. Circulation 2002; 106:1770-1780.
22. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999; 340:14-22. (Pubitemid 29024679)